{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:38:44Z","timestamp":1790743124337,"version":"4.1.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1124\/mol.115.099291","type":"journal-article","created":{"date-parts":[[2015,6,9]],"date-time":"2015-06-09T02:10:22Z","timestamp":1433815822000},"page":"401-420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)"],"prefix":"10.1016","volume":"88","author":[{"given":"Harriet","family":"Hammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Bader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Ehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer","family":"Bundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Bunch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Hoestgaard-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.-U.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper F.","family":"Bastlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gramowski-Vo\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.115.099291_bib1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1124\/mol.65.1.68","article-title":"Defining the propofol binding site location on the GABAA receptor","volume":"65","author":"Bali","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib2","first-page":"1304","article-title":"A clinical study of methaqualone: a new nonbarbiturate hypnotic","volume":"85","author":"Barcelo","year":"1961","journal-title":"Can Med Assoc J"},{"key":"10.1124\/mol.115.099291_bib3","series-title":"Medical Toxicology of Drug Abuse","first-page":"504","article-title":"Methaqualone and related compounds","author":"Barceloux","year":"2012"},{"key":"10.1124\/mol.115.099291_bib4","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J Neurosci"},{"key":"10.1124\/mol.115.099291_bib5","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.94.20.11031","article-title":"The interaction of the general anesthetic etomidate with the \u03b3-aminobutyric acid type A receptor is influenced by a single amino acid","volume":"94","author":"Belelli","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.115.099291_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABAA receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/mol.115.099291_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human \u03b14\u03b23\u03b4 GABAA receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0706796","article-title":"Mechanism of action of benzodiazepines on GABAA receptors","volume":"148","author":"Campo-Soria","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib9","series-title":"Quaaludes: The Quest for Oblivion","author":"Carroll","year":"1985"},{"key":"10.1124\/mol.115.099291_bib10","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1007\/s00213-014-3568-4","article-title":"11-trifluoromethyl-phenyldiazirinyl neurosteroid analogues: potent general anesthetics and photolabeling reagents for GABAA receptors","volume":"231","author":"Chen","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.115.099291_bib11","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1021\/bi201772m","article-title":"Mapping general anesthetic binding site(s) in human \u03b11\u03b23 \u03b3-aminobutyric acid type A receptors with [\u00b3H]TDBzl-etomidate, a photoreactive etomidate analogue","volume":"51","author":"Chiara","year":"2012","journal-title":"Biochemistry"},{"key":"10.1124\/mol.115.099291_bib12","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib13","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1124\/jpet.110.174144","article-title":"A novel family of negative and positive allosteric modulators of NMDA receptors","volume":"335","author":"Costa","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.115.099291_bib14","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for \u03b15 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.115.099291_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.115.099291_bib16","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/ALN.0b013e3181b55fae","article-title":"\u03b3-amino butyric acid type A receptor mutations at \u03b22N265 alter etomidate efficacy while preserving basal and agonist-dependent activity","volume":"111","author":"Desai","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.115.099291_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.104.001230","article-title":"The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A\/1B knockout mouse model","volume":"33","author":"Doran","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.115.099291_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/10826087609056173","article-title":"Methaqualone misuse: foreign experience and United States drug control policy","volume":"11","author":"Falco","year":"1976","journal-title":"Int J Addict"},{"key":"10.1124\/mol.115.099291_bib19","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1124\/mol.104.002543","article-title":"Pentobarbital differentially modulates \u03b11\u03b23\u03b4 and \u03b11\u03b23\u03b32L GABAA receptor currents","volume":"66","author":"Feng","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1124\/mol.104.003426","article-title":"Multiple actions of propofol on \u03b1\u03b2\u03b3 and \u03b1\u03b2\u03b4 GABAA receptors","volume":"66","author":"Feng","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib21","doi-asserted-by":"crossref","first-page":"23614","DOI":"10.1074\/jbc.M110.122564","article-title":"Barbiturates require the N terminus and first transmembrane domain of the \u03b4 subunit for enhancement of \u03b11\u03b23\u03b4 GABAA receptor currents","volume":"285","author":"Feng","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib22","series-title":"Drugs The Straight Facts: Qualuudes","author":"Gass","year":"2008"},{"key":"10.1124\/mol.115.099291_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0006-2952(96)00094-9","article-title":"Biochemical evaluations of the effects of loreclezole and propofol on the GABAA receptor in rat brain","volume":"51","author":"Ghiani","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.115.099291_bib24","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1523\/JNEUROSCI.5663-11.2012","article-title":"Benzodiazepines modulate GABAA receptors by regulating the preactivation step after GABA binding","volume":"32","author":"Gielen","year":"2012","journal-title":"J Neurosci"},{"key":"10.1124\/mol.115.099291_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1460-9568.2006.04892.x","article-title":"Functional screening of traditional antidepressants with primary cortical neuronal networks grown on multielectrode neurochips","volume":"24","author":"Gramowski","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.115.099291_bib26","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1111\/j.0953-816X.2004.03373.x","article-title":"Substance identification by quantitative characterization of oscillatory activity in murine spinal cord networks on microelectrode arrays","volume":"19","author":"Gramowski","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.115.099291_bib27","first-page":"410","article-title":"Detecting neurotoxicity through electrical activity changes of neuronal networks on multielectrode neurochips","volume":"23","author":"Gramowski","year":"2006","journal-title":"ALTEX"},{"key":"10.1124\/mol.115.099291_bib28","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0028-3908(96)00060-3","article-title":"A behavioural and neurochemical study in rats of the pharmacology of loreclezole, a novel allosteric modulator of the GABAA receptor","volume":"35","author":"Green","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib29","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0028-3908(01)00196-4","article-title":"Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement","volume":"42","author":"Greenfield","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib30","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1046\/j.1460-9568.1999.00709.x","article-title":"Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid","volume":"11","author":"Halliwell","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.115.099291_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pharmthera.2007.03.007","article-title":"Neurosteroid modulation of synaptic and extrasynaptic GABAA receptors","volume":"116","author":"Herd","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.115.099291_bib32","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.shpsc.2011.05.005","article-title":"Blockbusters and controlled substances: Miltown, Quaalude, and consumer demand for drugs in postwar America","volume":"42","author":"Herzberg","year":"2011","journal-title":"Stud Hist Philos Biol Biomed Sci"},{"key":"10.1124\/mol.115.099291_bib33","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10139","article-title":"Principles of activation and permeation in an anion-selective Cys-loop receptor","volume":"474","author":"Hibbs","year":"2011","journal-title":"Nature"},{"key":"10.1124\/mol.115.099291_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1017\/S031716710002998X","article-title":"Receptive-field size of S1 cortical neurones is altered by methaqualone via a GABA mechanism","volume":"17","author":"Hicks","year":"1990","journal-title":"Can J Neurol Sci"},{"key":"10.1124\/mol.115.099291_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"Subunit-dependent interaction of the general anaesthetic etomidate with the \u03b3-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib36","doi-asserted-by":"crossref","first-page":"16256","DOI":"10.1523\/JNEUROSCI.1495-14.2014","article-title":"Probing \u03b14\u03b2\u03b4 GABAA receptor heterogeneity: differential regional effects of a functionally selective \u03b14\u03b21\u03b4\/\u03b14\u03b23\u03b4 receptor agonist on tonic and phasic inhibition in rat brain","volume":"34","author":"Hoestgaard-Jensen","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/mol.115.099291_bib37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bph.12340","article-title":"The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors","volume":"170","author":"Hoestgaard-Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuropharm.2008.07.050","article-title":"Conserved site for neurosteroid modulation of GABAA receptors","volume":"56","author":"Hosie","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1124\/mol.115.099291_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004850-198804000-00001","article-title":"Methaqualone","volume":"3","author":"Ionescu-Pioggia","year":"1988","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1124\/mol.115.099291_bib41","doi-asserted-by":"crossref","first-page":"10141","DOI":"10.1074\/jbc.M109.079319","article-title":"Ginkgolide X is a potent antagonist of anionic Cys-loop receptors with a unique selectivity profile at glycine receptors","volume":"285","author":"Jensen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib42","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the \u03b4 selective compound 2 (DS2) at human recombinant and rodent native GABAA receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.neuro.2010.04.001","article-title":"Microelectrode arrays: a physiologically based neurotoxicity testing platform for the 21st century","volume":"31","author":"Johnstone","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1124\/mol.115.099291_bib44","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bcp.2012.05.017","article-title":"Low nanomolar GABA effects at extrasynaptic \u03b14\u03b21\/\u03b23\u03b4 GABAA receptor subtypes indicate a different binding mode for GABA at these receptors","volume":"84","author":"Karim","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.115.099291_bib45","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00726-012-1456-y","article-title":"Potency of GABA at human recombinant GABAA receptors expressed in Xenopus oocytes: a mini review","volume":"44","author":"Karim","year":"2013","journal-title":"Amino Acids"},{"key":"10.1124\/mol.115.099291_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.neuropharm.2010.07.010","article-title":"Allosteric modulation of G protein-coupled receptors: a pharmacological perspective","volume":"60","author":"Keov","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2007.04.018","article-title":"Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity","volume":"53","author":"Khom","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3570549","article-title":"Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice","volume":"7","author":"Kimball","year":"1957","journal-title":"Radiat Res"},{"key":"10.1124\/mol.115.099291_bib49","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0028-3908(01)00141-1","article-title":"Methionine 286 in transmembrane domain 3 of the GABAA receptor \u03b2 subunit controls a binding cavity for propofol and other alkylphenol general anesthetics","volume":"41","author":"Krasowski","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/mol.114.094540","article-title":"Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site","volume":"87","author":"Lansdell","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2165\/00003088-199936030-00003","article-title":"Prediction of hepatic metabolic clearance based on interspecies allometric scaling techniques and in vitro-in vivo correlations","volume":"36","author":"Lav\u00e9","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/mol.115.099291_bib52","doi-asserted-by":"crossref","first-page":"11599","DOI":"10.1523\/JNEUROSCI.3467-06.2006","article-title":"Identification of a GABAA receptor anesthetic binding site at subunit interfaces by photolabeling with an etomidate analog","volume":"26","author":"Li","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/mol.115.099291_bib53","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res"},{"key":"10.1124\/mol.115.099291_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1124\/mol.108.052886","article-title":"Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity","volume":"75","author":"Marlo","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/sj.bjp.0705159","article-title":"Positive allosteric modulation of the human metabotropic glutamate receptor 4 (hmGluR4) by SIB-1893 and MPEP","volume":"138","author":"Mathiesen","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib56","doi-asserted-by":"crossref","unstructured":"McCarthy G, Myers B, Siegfried N (2005) Treatment for methaqualone dependence in adults. Cochrane Database Syst Rev (2):CD004146.","DOI":"10.1002\/14651858.CD004146.pub2"},{"key":"10.1124\/mol.115.099291_bib57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2008.08.011","article-title":"Etomidate, propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant \u03b14\u03b23\u03b4 and \u03b14\u03b23 GABAA receptors expressed in HEK cells","volume":"56","author":"Meera","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib58","first-page":"1","article-title":"GABA potency at GABAA receptors found in synaptic and extrasynaptic zones","volume":"6","author":"Mortensen","year":"2011","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/mol.115.099291_bib59","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1097\/00001756-199908020-00005","article-title":"Facilitation of miniature GABAergic currents by chlorpromazine in cultured rat hippocampal cells","volume":"10","author":"Mozrzymas","year":"1999","journal-title":"Neuroreport"},{"key":"10.1124\/mol.115.099291_bib60","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1523\/JNEUROSCI.19-07-02474.1999","article-title":"Chlorpromazine inhibits miniature GABAergic currents by reducing the binding and by increasing the unbinding rate of GABAA receptors","volume":"19","author":"Mozrzymas","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/mol.115.099291_bib61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF00497002","article-title":"Benzodiazepine receptor binding: the interactions of some non-benzodiazepine drugs with specific [3H] diazepam binding to rat brain synaptosomal membranes","volume":"305","author":"M\u00fcller","year":"1978","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/mol.115.099291_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00426965","article-title":"Involvement of \u03b3-amino butyric acid (GABA) in the anticonvulsant action of methaqualone","volume":"57","author":"Naik","year":"1978","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.115.099291_bib63","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fneng.2011.00004","article-title":"Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals","volume":"4","author":"Novellino","year":"2011","journal-title":"Front Neuroeng"},{"key":"10.1124\/mol.115.099291_bib64","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of \u03b3-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.115.099291_bib65","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuropharm.2013.03.008","article-title":"The multitarget opioid ligand LP1\u2019s effects in persistent pain and in primary cell neuronal cultures","volume":"71","author":"Parenti","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib66","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.adolescence.2003.11.013","article-title":"Trends in adolescent alcohol and other drug use: findings from three sentinel sites in South Africa (1997-2001)","volume":"27","author":"Parry","year":"2004","journal-title":"J Adolesc"},{"key":"10.1124\/mol.115.099291_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/j.1552-4604.1968.tb00100.x","article-title":"Quantitative analysis of the effect of methqualone on the human EEG","volume":"8","author":"Pfeiffer","year":"1968","journal-title":"J Clin Pharmacol J New Drugs"},{"key":"10.1124\/mol.115.099291_bib68","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1471-4159.1983.tb04758.x","article-title":"Modulation of [3H]muscimol binding in rat cerebellar and cerebral cortical membranes by picrotoxin, pentobarbitone, and etomidate","volume":"41","author":"Quast","year":"1983","journal-title":"J Neurochem"},{"key":"10.1124\/mol.115.099291_bib69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-011-2593-9","article-title":"Negative modulation of GABAA \u03b15 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats","volume":"221","author":"Redrobe","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/mol.115.099291_bib70","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/npp.2014.261","article-title":"Ketamine: promising path or false prophecy in the development of novel therapeutics for mood disorders?","volume":"40","author":"Sanacora","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/mol.115.099291_bib71","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.neuint.2007.10.016","article-title":"Differential pharmacological properties of GABAA\/benzodiazepine receptor complex in dorsal compared to ventral rat hippocampus","volume":"52","author":"Sarantis","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1124\/mol.115.099291_bib72","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/ncomms2682","article-title":"Structural basis for potentiation by alcohols and anaesthetics in a ligand-gated ion channel","volume":"4","author":"Sauguet","year":"2013","journal-title":"Nat Commun"},{"key":"10.1124\/mol.115.099291_bib73","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0013-4694(77)90010-4","article-title":"Electroencephalographic studies with i.v. methaqualone in man","volume":"43","author":"Saxena","year":"1977","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1124\/mol.115.099291_bib74","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1469-7793.2000.00649.x","article-title":"Structural domains of the human GABAA receptor \u03b23 subunit involved in the actions of pentobarbital","volume":"524","author":"Serafini","year":"2000","journal-title":"J Physiol"},{"key":"10.1124\/mol.115.099291_bib75","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1476-5381.2009.00267.x","article-title":"To scale or not to scale: the principles of dose extrapolation","volume":"157","author":"Sharma","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1124\/mol.115.099291_bib77","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.0022-3042.2001.00682.x","article-title":"Molecular determinants for the action of general anesthetics at recombinant \u03b12\u03b23\u03b32 \u03b3-aminobutyric acidA receptors","volume":"80","author":"Siegwart","year":"2002","journal-title":"J Neurochem"},{"key":"10.1124\/mol.115.099291_bib78","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156802611794863562","article-title":"A closer look at the high affinity benzodiazepine binding site on GABAA receptors","volume":"11","author":"Sigel","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/mol.115.099291_bib79","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0922-4106(95)90130-2","article-title":"Allosteric modulation of [3H]flunitrazepam binding to recombinant GABAA receptors","volume":"291","author":"Slany","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib80","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0269881105051524","article-title":"The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines","volume":"19","author":"Stanley","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1124\/mol.115.099291_bib81","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1124\/mol.108.050500","article-title":"Tryptophan mutations at azi-etomidate photo-incorporation sites on \u03b11 or \u03b22 subunits enhance GABAA receptor gating and reduce etomidate modulation","volume":"74","author":"Stewart","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.115.099291_bib82","doi-asserted-by":"crossref","first-page":"30373","DOI":"10.1074\/jbc.M113.494583","article-title":"Cysteine substitutions define etomidate binding and gating linkages in the \u03b1-M1 domain of \u03b3-aminobutyric acid type A (GABAA) receptors","volume":"288","author":"Stewart","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib83","doi-asserted-by":"crossref","first-page":"e111470","DOI":"10.1371\/journal.pone.0111470","article-title":"Mutations at beta N265 in \u03b3-aminobutyric acid type A receptors alter both binding affinity and efficacy of potent anesthetics","volume":"9","author":"Stewart","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1124\/mol.115.099291_bib84","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at \u03b4-containing GABAA receptors: functional selectivity for extrasynaptic receptors is dependent on the absence of \u03b32","volume":"316","author":"St\u00f3rustovu","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.115.099291_bib85","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bjp.0705689","article-title":"Salicylidene salicylhydrazide, a selective inhibitor of \u03b21-containing GABAA receptors","volume":"142","author":"Thompson","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib86","doi-asserted-by":"crossref","first-page":"25241","DOI":"10.1074\/jbc.M112.360370","article-title":"Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site","volume":"287","author":"Trattnig","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib87","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0896-6273(94)90330-1","article-title":"A novel allosteric modulatory site on the GABAA receptor \u03b2 subunit","volume":"12","author":"Wafford","year":"1994","journal-title":"Neuron"},{"key":"10.1124\/mol.115.099291_bib88","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2008.08.004","article-title":"Novel compounds selectively enhance \u03b4 subunit containing GABAA receptors and increase tonic currents in thalamus","volume":"56","author":"Wafford","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/mol.115.099291_bib89","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/81800","article-title":"Benzodiazepines act on GABAA receptors via two distinct and separable mechanisms","volume":"3","author":"Walters","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/mol.115.099291_bib90","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1359-6446(03)02703-X","article-title":"GABA-A receptor subtypes in the brain: a paradigm for CNS drug discovery?","volume":"8","author":"Whiting","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1124\/mol.115.099291_bib91","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0021-9258(18)45961-3","article-title":"A single histidine in GABAA receptors is essential for benzodiazepine agonist binding","volume":"267","author":"Wieland","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.115.099291_bib92","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the \u03b3-aminobutyric acid type A receptor is determined by a single amino acid in the \u03b22 and \u03b23 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.115.099291_bib93","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1460-9568.1997.tb01641.x","article-title":"Pharmacological and physiological characterization of murine homomeric \u03b23 GABAA receptors","volume":"9","author":"Wooltorton","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1124\/mol.115.099291_bib94","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0014-2999(95)00856-X","article-title":"Loreclezole modulates [35S]t-butylbicyclophosphorothionate and [3H]flunitrazepam binding via a distinct site on the GABAA receptor complex","volume":"300","author":"Xue","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.115.099291_bib95","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/sj.bjp.0701269","article-title":"Interactions between loreclezole, chlormethiazole and pentobarbitone at GABAA receptors: functional and binding studies","volume":"121","author":"Zhong","year":"1997","journal-title":"Br J Pharmacol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24031420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24031420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.115.099291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T10:08:27Z","timestamp":1739959707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24031420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0026895X24031420"],"URL":"https:\/\/doi.org\/10.1124\/mol.115.099291","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude)","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.115.099291","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}